Nussloch, Germany

Steffen Waglöhner

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Steffen Waglöhner: Innovator in Lactam Production

Introduction

Steffen Waglöhner is a distinguished inventor based in Nussloch, Germany. With a focus on chemical processes, he has made significant contributions to the field through his innovative methods of producing lactams. His work not only highlights his inventive prowess but also the importance of collaboration in scientific advancements.

Latest Patents

Waglöhner holds a patent for a groundbreaking method for producing C4-C15 lactams. This invention involves a unique process where a C-C-alkyl nitrite is reacted with a C-C-cycloalkane and illuminated with a light-emitting diode during the reaction. This innovative approach results in the formation of a C-C-cyclohexanone oxime, which is subsequently converted into the desired C4-C15 lactam. Moreover, the C-C-alcohol generated in the process is recycled back into the preparation of the C-C-alkyl nitrite, showcasing an efficient and sustainable method for lactam production.

Career Highlights

Steffen Waglöhner is currently employed at BASF SE Corporation, where he continues to explore his passion for chemical innovation. His work aligns with the company’s commitment to enhancing chemical processes and developing new products that are advantageous for various industries.

Collaborations

Throughout his career, Waglöhner has collaborated with notable colleagues such as Richard Dehn and Ahmad Dehestani. These partnerships have been vital in fostering a creative environment that drives innovation and pushes the boundaries of current scientific understanding.

Conclusion

Steffen Waglöhner stands out as an exemplary inventor whose work in lactam production reflects both ingenuity and practical application. His patent serves as a testament to his expertise and his commitment to advancing chemical processes, benefiting both his company and the broader scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…